Gene & Cell Therapies (GCT) –The Future of Cost Containment and Risk Forecasting Published date: 01 Apr 2022 Published by: Reinsurance Content Type: Blog We're living in a time when previously incurable diseases and illnesses will be curable with novel treatments like gene and cell ... By Agostino Marotta, Former US Medical Underwriting Manager Go to Gene & Cell Therapies (GCT) –The Future of Cost Containment and Risk Forecasting
How the medical community adapted treatments to save COVID-19 patients Published date: 08 Mar 2021 Published by: Swiss Re Institute Content Type: Blog Early on in the pandemic we had no understanding of the behavior of the disease. By Nicola Charlton, Former UW R&D Senior Medical Officer, Global Core Solutions, UW & MedRe Go to How the medical community adapted treatments to save COVID-19 patients
Lessons learned in containing a borderless pandemic Published date: 02 Mar 2021 Published by: Swiss Re Institute Content Type: Blog Rapid action early on saves lives and reduces economic disruption – so in the future we must act faster. By Stephen Kramer, Former Emerging Risks Research Lead, SRI Research & Engagement Go to Lessons learned in containing a borderless pandemic
Cancer survivors’ Right to be Forgotten (RTBF) Implications for Life & Health insurers Published date: 06 Jun 2025 Published by: Reinsurance Content Type: Publication The Right to be Forgotten allows cancer survivors to withhold past diagnoses, reshaping insurance norms and requiring localised ... By Multiple Authors Go to Cancer survivors’ Right to be Forgotten (RTBF) Implications for Life & Health insurers
Screening Impact on Cancer Incidence in China: Past, Present and Future Published date: 07 May 2025 Published by: Reinsurance Content Type: Publication Analysis of the impact of screening on cancer trends in China based on consumer survey and medical evidence. Discusses prognosis ... By Minfu He, Life & Health R&D Manager, CUO L&H Reinsurance Go to Screening Impact on Cancer Incidence in China: Past, Present and Future
Insurers, here's how behavioural science can help you navigate the GLP-1 medication era Published date: 02 Apr 2025 Published by: Reinsurance Content Type: Publication This publication emphasizes the significance of integrating behavioural science methodologies with the utilization of GLP-1 ... By Multiple Authors Go to Insurers, here's how behavioural science can help you navigate the GLP-1 medication era
GLP-1 drugs: promise or peril Published date: 10 Dec 2025 Published by: Reinsurance Content Type: Event The crisis in metabolic health is deepening and we're here to drive meaningful change. As a trusted source of knowledge on the ... Conference Location: Online Go to GLP-1 drugs: promise or peril
The future of excess mortality after COVID-19 Published date: 16 Sep 2024 Published by: Swiss Re Institute Content Type: Publication Investigate the prospective trajectory of excess mortality rates subsequent to the COVID-19 pandemic and its potential ... By Multiple Authors Go to The future of excess mortality after COVID-19
Emerging risks - SONAR 2022 Published date: 16 Jun 2022 Published by: Swiss Re Institute Content Type: Publication SONAR 2022: Climate change & the transition to a low-carbon economy, real & hyped technological disruptions, increased global ... By Multiple Authors Go to Emerging risks - SONAR 2022
SONAR 2021: New emerging risk insights Published date: 08 Jun 2021 Published by: Swiss Re Institute Content Type: Publication COVID-19 crisis dominates risk landscape. Emerging risks arise from developments in human-machine interaction, connected ... By Multiple Authors Go to SONAR 2021: New emerging risk insights
